Drug maker Upsher-Smith Labs has introduced a new product to its prenatal vitamin line, the company said Tuesday.

Upsher-Smith Labs has launched a probiotic dietary supplement specifically designed for women to promote digestive, feminine and immune health, the company said.

Upsher-Smith Labs on Wednesday announced that it has agreed to acquire Proximagen Group, a European biotechnology company focused on the development and commercialization of novel therapeutics for diseases of the central nervous system and inflammation.

Drug maker Upsher-Smith Labs has launched a prenatal vitamin designed to help relieve morning sickness, the company said Monday.

Upsher-Smith Labs has started a late-stage clinical trial of a drug for treating patients with a rare and severe form of epilepsy, the drug maker said Monday.